1h Free Analyst Time
GeoVax Labs Inc (GOVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - Analyst's summarization of the company's business strategy.
- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
GeoVax Labs Inc (GeoVax) is a biotechnology company that develops immunotherapies and vaccines against cancers and various infectious diseases. GeoVax develops vaccines using its novel patented Modified Vaccinia Ankara-Virus like Particle (MVA-VLP) vector vaccine platform focused on therapy areas such as infectious diseases like HIV, Lassa fever, Ebola, Zika virus, malaria, Hepatitis B, coronavirus, and cancers related to solid tumors and HPV-associated head and neck cancer. It has partnerships for preclinical and clinical testing with various government, academic and corporate entities, including the Centers for Disease Control and Prevention (CDC), Leidos Inc, Scripps Research Institute, and Emory University. GeoVax is headquartered in Smyrna, Georgia, the US.GeoVax Labs Inc Key Recent Developments
- May 31, 2023: GeoVax partners with ABL to advance cGMP production of vaccine candidates
- May 25, 2023: GeoVax to participate in upcoming Industry Meetings
- May 04, 2023: GeoVax reports 2023 First Quarter financial results and provides corporate update
- Apr 26, 2023: GeoVax to participate in the 4th Symposium on Infectious Diseases in the Immunocompromised Host
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Protein Sciences Corp
- Curevac NV
- BioNTech SE
- Pfizer Inc
- Novavax Inc
- GlaxoSmithKline AG
- Moderna Inc
- Inovio Pharmaceuticals Inc
- Sanofi
- Juno Therapeutics Inc
- Johnson & Johnson
- Janssen Pharmaceuticals Inc
- Dynavax Technologies Corp
- Ayala Pharmaceuticals Inc.
- Profectus BioSciences Inc
- Merck & Co Inc
- AstraZeneca Plc
- Pfizer Inc
- Novavax Inc
- GlaxoSmithKline AG
- Advaxis Inc
- Profectus BioSciences Inc
- AstraZeneca Plc
- Inovio Pharmaceuticals Inc
- Sanofi
- Dynavax Technologies Corp
- Merck & Co Inc
- Aduro Biotech Inc
- Protein Sciences Corp
- Juno Therapeutics Inc
- Johnson & Johnson
- BioNTech SE
- Moderna Inc
- Curevac NV
- Janssen Pharmaceuticals Inc